On Tuesday, I wrote about an analysis of how often the Food and Drug Administration follows the advice of its expert advisory panels on whetheror not to approve a new drug.
In a statement to parliament Mr Khurshid said that Italian requests "for diplomatic orexpert level meetings" to consider the issue of jurisdiction in the case - "or whether it can be referred to arbitration or any other judicial mechanism cannot be accepted".